GYRE
Gyre Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.86
+6.52%0
Insider buys (3m)
7
Insider sells (3m)
-$414.4K
Net value (3m)
+6.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 4, 2026 | Kirkby Maxwell · director | A-Award | 40,000 | $6.11 |
| Aug 4, 2026 | Weston Claire · director | A-Award | 40,000 | $6.11 |
| Jun 30, 2026 | Zhang Ping · director | A-Award | 40,000 | $5.95 |
| Jun 30, 2026 | Epstein David M. · director | A-Award | 40,000 | $5.95 |
| Jun 30, 2026 | Weng Dan · director | A-Award | 40,000 | $5.95 |
| Jun 30, 2026 | Parry Renate · director | A-Award | 40,000 | $5.95 |
| Jun 30, 2026 | Nussbaum Rodney L · director | A-Award | 40,000 | $5.95 |
| Jun 30, 2026 | Carmichael Gordon · director | A-Award | 40,000 | $5.95 |
| Jun 22, 2026 | Ye Weiguo · officer: Chief Operating Officer | M-Exempt | 3,000 | $0.75 |
| Jun 22, 2026 | Ye Weiguo · officer: Chief Operating Officer | Sale | 3,000 | $6.15 |
| Jun 22, 2026 | Ye Weiguo · officer: Chief Operating Officer | M-Exempt | 5,000 | $0.75 |
| Jun 22, 2026 | Ye Weiguo · officer: Chief Operating Officer | Sale | 5,000 | $6.24 |
| Jun 15, 2026 | Ye Weiguo · officer: Chief Operating Officer | M-Exempt | 2,800 | $0.75 |
| Jun 15, 2026 | Ye Weiguo · officer: Chief Operating Officer | Sale | 2,800 | $6.17 |
| Jun 11, 2026 | Ye Weiguo · officer: Chief Operating Officer | M-Exempt | 6,418 | $0.75 |
| Jun 11, 2026 | Ye Weiguo · officer: Chief Operating Officer | M-Exempt | 14,500 | $0.75 |
| Jun 11, 2026 | Ye Weiguo · officer: Chief Operating Officer | Sale | 14,500 | $6.14 |
| Jun 11, 2026 | Ye Weiguo · officer: Chief Operating Officer | Sale | 6,418 | $6.21 |
| Jun 10, 2026 | Bergmann Joshua Benjamin · officer: GC and Corporate Secretary | A-Award | 50,000 | $6.05 |
| Jun 10, 2026 | Luo Ying · director, officer: Chief Executive Officer | A-Award | 120,000 | $6.05 |
| Jun 8, 2026 | Ye Weiguo · officer: Chief Operating Officer | M-Exempt | 15,401 | $0.75 |
| Jun 8, 2026 | Ye Weiguo · officer: Chief Operating Officer | Sale | 19,575 | $6.13 |
| Jun 8, 2026 | Ye Weiguo · officer: Chief Operating Officer | Sale | 15,401 | $6.40 |
| Jun 8, 2026 | Ye Weiguo · officer: Chief Operating Officer | M-Exempt | 19,575 | $0.75 |
| May 27, 2026 | Ye Weiguo · officer: Chief Operating Officer | M-Exempt | 3,500 | $0.75 |
| May 27, 2026 | Ye Weiguo · officer: Chief Operating Officer | Sale | 4,000 | $6.10 |
| May 27, 2026 | Ye Weiguo · officer: Chief Operating Officer | M-Exempt | 4,000 | $0.75 |
| May 27, 2026 | Ye Weiguo · officer: Chief Operating Officer | Sale | 3,500 | $6.08 |
| May 22, 2026 | Ye Weiguo · officer: Chief Operating Officer | M-Exempt | 12,820 | $0.75 |
| May 22, 2026 | Ye Weiguo · officer: Chief Operating Officer | M-Exempt | 9,400 | $0.75 |
Institutional positioning
13F filings over the trailing two quarters
New 29Increased 50Reduced 20Sold out 7
| Filer | Action | Shares | Filed |
|---|---|---|---|
| HSG Holding Ltd | New Position | 3,750,299 | Aug 13, 2026 |
| BlackRock, Inc. | Increased | 993,943 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 984,204 | May 15, 2026 |
| Octagon Capital Advisors LP | New Position | 954,416 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 876,927 | Aug 13, 2026 |
| BLACKROCK, INC. | Increased | 758,630 | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 532,950 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 431,414 | May 15, 2026 |
| STATE STREET CORP | Increased | 245,402 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 216,326 | May 15, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Increased | 184,286 | Aug 14, 2026 |
| SBI SECURITIES CO., LTD. | Increased | 170,837 | Apr 28, 2026 |
| NORTHERN TRUST CORP | Increased | 169,537 | Aug 13, 2026 |
| SBI Securities Co., Ltd. | Reduced | 166,750 | Jul 23, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Reduced | 165,238 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 4, 2026